Top Markets
#1 DogBull DogBull +132.87%
#2 Harmony Harmony +111.36%
#3 Zama Zama +40.94%
#4 Akedo Akedo +39.40%
#5 Derive Derive +35.13%
#6 Celer Network Celer Network +27.92%
#7 Bedrock Bedrock +27.80%
#8 OpenServ OpenServ +27.70%
#9 Gravity Gravity +27.67%
#10 BSquared Network BSquared Network +25.48%
Coin of the day
DogBull DogBull
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
GSK plc GSK plc

GSK plc

GSK
Classifica tra le azioni #9382
GSK plc is a global pharmaceutical and healthcare company, deeply involved in... GSK plc is a global pharmaceutical and healthcare company, deeply involved in the research, development, production, and commercialization of a diverse range of medicinal and wellness products. Its operations span the United Kingdom, the United States, and numerous other international markets. The company structures its operations across four primary divisions: Pharmaceuticals, Pharmaceutical R&D, Vaccines, and Consumer Healthcare. Within its Pharmaceuticals segment, GSK provides treatments addressing a wide array of therapeutic areas. These include respiratory conditions, HIV, immuno-inflammatory diseases, oncology, viral infections, central nervous system disorders, cardiovascular and urogenital health, metabolic imbalances, bacterial infections, and dermatological issues. The Consumer Healthcare division offers products across categories such as wellness, oral hygiene, nutritional supplements, and skin health. These consumer offerings come in a variety of formats, including oral dosage forms (e.g., tablets, syrups, lozenges, gummies, soft chews, effervescents), topical applications (e.g., gels, creams, patches, lip balms), nasal sprays, and a comprehensive range of oral hygiene products (e.g., toothpastes, mouthwashes, denture care items), alongside other specialized formulations like infant drops and wipes. GSK actively engages in various collaborative ventures. Its collaboration agreements include partnerships with 23andMe, Lyell Immunopharma, Inc., Novartis, Sanofi SA, Surface Oncology, Progentec Diagnostics, Inc., Alector, Inc., and CureVac AG. Additionally, the company maintains strategic alliances with IDEAYA Biosciences, Inc. and Vir Biotechnology, Inc. Originally established in 1715, the company operated under the name GlaxoSmithKline plc until its rebranding to GSK plc in May 2022. Its corporate headquarters are situated in Brentford, United Kingdom.
Prezzo delle azioni
$25.28
Ultima sincronizzazione: 2026-09-18
Capitalizzazione di mercato
$1.01B
Variazione (1 giorno)
-2.29%
Variazione (1 anno)
-37.84%
Paese
GB
Scambia GSK plc (GSK)

Categoria

Healthcare
Rapporto P/B per GSK plc (GSK)
Rapporto P/B al September 2026 TTM: 4.22
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di GSK plc, il rapporto P/B attuale (TTM) è 4.22. Alla fine del 2024, era pari a 4.02.
Storico del rapporto P/B per GSK plc da 2000 a 2026
Rapporto P/B alla fine di ogni anno
Anno Rapporto P/B Cambia
2026 (TTM) 4.22 -6.46%
2025 4.51 12.39%
2024 4.02 -8.79%
2023 4.40 -19.38%
2022 5.46 58.21%
2021 3.45 -6.69%
2020 3.70 -37.66%
2019 5.93 -56.31%
2018 13.58 -101.77%
2017 -767.86 -1,506.98%
2016 54.57 420.72%
2015 10.48 -16.42%
2014 12.54 39.48%
2013 8.99 -1.42%
2012 9.12 22.53%
2011 7.44 29.83%
2010 5.73 6.13%
2009 5.40 -20.54%
2008 6.80 14.36%
2007 5.95 -10.28%
2006 6.63 -28.07%
2005 9.21 -6.90%
2004 9.90 -16.16%
2003 11.80 36.40%
2002 8.65 -22.90%
2001 11.22 -6.68%
2000 12.02 0.00%
Rapporto P/B per aziende simili o concorrenti
Azienda Rapporto P/B Differenza del rapporto P/B Il paese
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
 29.9692 610.39%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 7.6479 81.29%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 -78.0908 -1,951.06%
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
 8.4776 100.95%
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 8.5385 102.40%
US